Observational study / 2008
In a cohort of breast cancer survivors, 75.6% had low serum 25(OH)D, and advanced disease stage was associated with lower vitamin D levels.
Researchers examined serum 25(OH)D concentrations in 790 breast cancer survivors from the Health, Eating, Activity, and Lifestyle study. Overall, 597 women (75.6%) had low serum 25(OH)D, with a total mean of 24.8 +/- 10.4 ng/mL, which was lower in African Americans (18.1 +/- 8.7 ng/mL) and Hispanics (22.1 +/- 9.2 ng/mL). Women with localized (P = 0.05) or regional (P = 0.03) breast cancer had lower levels than those with in situ disease. In multivariate regression models controlling for age, BMI, race-ethnicity, geography, season, physical activity, diet, and treatments, stage of disease independently predicted serum 25(OH)D (P = 0.02).
Shows an association, not proof of cause and effect.
- Study type
- Cross-sectional study
- Who was studied
- 790 breast cancer survivors from western Washington state, New Mexico, and Los Angeles County
- What was measured
- Serum concentrations of 25-hydroxyvitamin D [25(OH)D] and associations with disease stage
THE PAPER
Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors.
Neuhouser ML, Sorensen B, Hollis BW, Ambs A, Ulrich CM, McTiernan A, Bernstein L, Wayne S, Gilliland F, Baumgartner K, Baumgartner R, Ballard-Barbash R. Am J Clin Nutr, 2008.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.